VMP 42267511000001104

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Acamprosate 333mg gastro-resistant tablets
BNF code 0410010A0AAAAAA
Virtual Therapeutic Moiety Acamprosate
Date identifier became valid 22 Sep 2023
Previous product identifier 323342002
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Acamprosate calcium
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 333.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tabletgastro-resistant.oral
Dose Form
Formulation Gastro-resistant tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Acamprosate 333mg gastro-resistant tablets (AAH Hillcross)
Acamprosate 333mg gastro-resistant tablets (A A H Pharmaceuticals Ltd)
Acamprosate 333mg gastro-resistant tablets (Alliance Healthcare (Distribution) Ltd)
Acamprosate 333mg gastro-resistant tablets (Medihealth (Northern) Ltd)
Acamprosate 333mg gastro-resistant tablets (Sigma Pharmaceuticals Plc)
Acamprosate 333mg gastro-resistant tablets (Viatris UK Healthcare Ltd)
Campral EC 333mg tablets (Merck Serono Ltd)
Virtual Medicinal Product Packs
Acamprosate 333mg gastro-resistant tablets 168 tablet
Acamprosate 333mg gastro-resistant tablets 60 tablet
Acamprosate 333mg gastro-resistant tablets 80 tablet
Acamprosate 333mg gastro-resistant tablets 84 tablet

dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.

Feedback